LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.89 | 771.67 | 1824 | 2397 | 0.7607 | 0.6920 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.11 | 771.67 | 1811 | 2675 | 0.6770 | 0.6090 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.11 | 771.67 | 1914 | 2675 | 0.7155 | 0.6594 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.33 | 771.67 | 1979 | 2939 | 0.6733 | 0.6292 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.33 | 771.67 | 2079 | 2939 | 0.7073 | 0.6714 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 31.55 | 771.67 | 2182 | 3196 | 0.6826 | 0.6602 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 31.55 | 771.67 | 2267 | 3196 | 0.7092 | 0.6914 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 33.78 | 771.67 | 2410 | 3499 | 0.6887 | 0.6856 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 33.78 | 771.67 | 2446 | 3499 | 0.6989 | 0.6971 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.00 | 771.67 | 2593 | 3884 | 0.6675 | 0.6817 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 36.00 | 771.67 | 2634 | 3884 | 0.6780 | 0.6930 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.22 | 771.67 | 2836 | 4299 | 0.6596 | 0.6908 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 38.22 | 771.67 | 2843 | 4299 | 0.6612 | 0.6925 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.44 | 771.67 | 3070 | 4738 | 0.6479 | 0.6945 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 40.44 | 771.67 | 3087 | 4738 | 0.6515 | 0.6981 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.67 | 771.67 | 3352 | 5155 | 0.6502 | 0.7092 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.67 | 771.67 | 3379 | 5155 | 0.6554 | 0.7142 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.89 | 771.67 | 3694 | 5541 | 0.6666 | 0.7342 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.89 | 771.67 | 3749 | 5541 | 0.6765 | 0.7433 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.11 | 771.67 | 4062 | 5941 | 0.6837 | 0.7577 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.11 | 771.67 | 4068 | 5941 | 0.6847 | 0.7586 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.33 | 771.67 | 4477 | 6392 | 0.7003 | 0.7796 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.33 | 771.67 | 4448 | 6392 | 0.6958 | 0.7758 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.55 | 771.67 | 4790 | 6829 | 0.7013 | 0.7867 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.55 | 771.67 | 4853 | 6829 | 0.7106 | 0.7941 | MN20160304_L01 | K13 |